Navigation Links
Avoiding a cartography catastrophe
Date:2/4/2013

KNOXVILLE, TN Since the mid-nineteenth century, maps have helped elucidate the deadly mysteries of diseases like cholera and yellow fever. Yet today's global mapping of infectious diseases is considerably unreliable and may do little to inform the control of potential outbreaks, according to a new systematic mapping review of all clinically important infectious diseases known to humans.

Of the 355 infectious diseases assessed in the review, 174 showed a strong rationale for mapping and less than 5 percent of those have been mapped reliably. Unreliable mapping makes it difficult to fully understand the geographic scope and threat of disease and therefore make informed policy recommendations for managing it, write the authors of the study, which appears as open access on Feb. 4 in the journal Philosophical Transactions of the Royal Society B.

An online, open-access database, which accompanies the study, provides a quantitative scheme for evaluating the quality of data available for each infectious disease as well as specific mapping recommendations for each disease. Among the recommendations for improving disease cartography are the use of new crowdsourcing techniques to gather data, such as analyzing the content and frequency of Twitter messages about disease. Twitter feeds during the 2009 H1N1 flu outbreak, for example, predicted outbreaks sooner than traditional disease surveillance methods.

"We have shown that novel solutions exist to enable us to use up-to-date data and technology to rapidly improve our geographic knowledge of a wide range of clinically important pathogens," said Katherine Battle, one of the study's co-authors from the University of Oxford.

Unique to the review is the inclusion of how the basic reproduction rate, which is the primary epidemiological number used to determine the degree which a disease can spread through a population, might vary among pathogens.

"There is a clear need for better estimates of the potential growth of infectious diseases that allow spatial variations to be taken into consideration, and this paper is a wonderful contribution to help us meet this need," said Louis Gross, the director of the National Institute for Mathematical and Biological Synthesis, which sponsored a workshop in 2011 that produced the paper.


'/>"/>

Contact: Catherine Crawley
ccrawley@nimbios.org
865-974-9350
National Institute for Mathematical and Biological Synthesis (NIMBioS)
Source:Eurekalert  

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Avoiding a cartography catastrophe
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... Systems, Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & ... intelligence provider visiongain offers comprehensive analysis of ... that this market will generate revenues of $17.98 billion ... Systems acquired DVTEL Inc, a leader in software and ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , ... announced today the Clinical Reach Virtual Patient Encounter CONSULT module which enables ... the physician and clinical trial team. , Using the CONSULT module, patients and physicians ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader ... “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, ... providing practical tips, tools, and strategies for clinical researchers. , “The landscape of ...
Breaking Biology Technology: